Cytokinetics Inc. buy Cantor Fitzgerald
Start price
09.09.24
/
50%
€50.00
Target price
09.09.25
-
Performance (%)
-13.20%
End price
10.09.25
€43.40
Summary
This prediction ended on 10.09.25 with a price of €43.40. The price of Cytokinetics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.20%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | 2.274% | 2.274% | 62.874% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten

